AnGes' lead therapeutic set for progress following US Mitsubishi Tanabe deal
This article was originally published in Scrip
Executive Summary
The Japanese bioventure AnGes MG has reached a basic agreement with a new partner that will allow the delayed development programme for its most advanced pipeline project to move forward.